| ECM-receptor interaction |
2.18 |
0.00e+0 |
80/88 (90.91%) |
COL1A1;COL6A3;FN1;...
|
| Staphylococcus aureus infection |
2.10 |
0.00e+0 |
72/95 (75.79%) |
FGG;ITGAM;HLA-DQB1;...
|
| Malaria |
2.03 |
0.00e+0 |
44/50 (88%) |
IL1B;CCL2;TLR4;...
|
| Amoebiasis |
1.92 |
0.00e+0 |
99/102 (97.06%) |
IL1B;COL1A1;CTSG;...
|
| Focal adhesion |
1.92 |
0.00e+0 |
180/201 (89.55%) |
PDGFA;IGF1R;FLNB;...
|
| Pertussis |
1.92 |
1.86e-3 |
64/76 (84.21%) |
IL1B;CALML3;IL1A;...
|
| Systemic lupus erythematosus |
1.92 |
1.60e-3 |
45/135 (33.33%) |
CTSG;HLA-DQB1;HLA-DRB1;...
|
| Intestinal immune network for IgA production |
1.82 |
1.26e-2 |
38/48 (79.17%) |
CXCL12;HLA-DQB1;HLA-DRB1;...
|
| Hematopoietic cell lineage |
1.82 |
1.12e-2 |
90/99 (90.91%) |
IL1B;CD44;CD1D;...
|
| MicroRNAs in cancer |
1.81 |
1.01e-2 |
146/310 (47.1%) |
MARCKS;HMOX1;PDGFA;...
|
| Graft-versus-host disease |
1.80 |
1.02e-2 |
32/42 (76.19%) |
IL1B;IL1A;HLA-DQB1;...
|
| Type I diabetes mellitus |
1.76 |
1.86e-2 |
38/43 (88.37%) |
IL1B;IL1A;HLA-DQB1;...
|
| Cytokine-cytokine receptor interaction |
1.74 |
2.23e-2 |
246/295 (83.39%) |
IL1B;CCL2;LIF;...
|
| Inflammatory bowel disease |
1.73 |
2.47e-2 |
58/65 (89.23%) |
IL1B;IL1A;HLA-DQB1;...
|
| Asthma |
1.72 |
2.61e-2 |
25/31 (80.65%) |
RNASE3;HLA-DQB1;HLA-DRB1;...
|
| Arachidonic acid metabolism |
1.72 |
2.51e-2 |
48/61 (78.69%) |
AKR1C3;GPX2;PTGIS;...
|
| Proteoglycans in cancer |
1.71 |
2.63e-2 |
172/205 (83.9%) |
IGF1R;FLNB;CCND1;...
|
| Regulation of actin cytoskeleton |
1.71 |
2.92e-2 |
185/218 (84.86%) |
PDGFA;FGFR3;MYH11;...
|
| Viral protein interaction with cytokine and cytokine re... |
1.69 |
3.12e-2 |
84/100 (84%) |
CCL2;CXCL12;CXCL1;...
|
| Complement and coagulation cascades |
1.68 |
3.91e-2 |
76/85 (89.41%) |
PLAT;FGG;SERPINB2;...
|
| Protein digestion and absorption |
1.66 |
4.20e-2 |
78/103 (75.73%) |
COL1A1;COL11A1;COL6A3;...
|
| Legionellosis |
1.66 |
4.01e-2 |
51/57 (89.47%) |
IL1B;CXCL1;ITGAM;...
|
| IL-17 signaling pathway |
1.66 |
4.13e-2 |
84/94 (89.36%) |
IL1B;CCL2;CXCL1;...
|
| Antigen processing and presentation |
1.66 |
4.09e-2 |
60/78 (76.92%) |
PDIA3;HSPA5;HLA-DQB1;...
|
| PI3K-Akt signaling pathway |
1.65 |
3.98e-2 |
317/354 (89.55%) |
PDGFA;IGF1R;MYB;...
|
| Fluid shear stress and atherosclerosis |
1.65 |
3.95e-2 |
123/139 (88.49%) |
IL1B;HMOX1;PDGFA;...
|
| Rheumatoid arthritis |
1.65 |
3.89e-2 |
78/93 (83.87%) |
IL1B;CCL2;TEK;...
|
| Transcriptional misregulation in cancer |
1.64 |
3.87e-2 |
158/192 (82.29%) |
DUSP6;PDGFA;IGF1R;...
|
| Folate biosynthesis |
1.63 |
4.31e-2 |
23/26 (88.46%) |
AKR1C3;GGH;FPGS;...
|
| Sulfur metabolism |
1.61 |
4.99e-2 |
9/10 (90%) |
SQOR;TST;PAPSS1;...
|
| mRNA surveillance pathway |
-1.78 |
3.04e-2 |
71/98 (72.45%) |
DDX19A;GLE1;PABPC4;...
|
| Ribosome |
-2.00 |
0.00e+0 |
113/158 (71.52%) |
RPL36;RPL31;RPL36A;...
|
| Oxidative phosphorylation |
-2.06 |
0.00e+0 |
93/133 (69.92%) |
ATP12A;NDUFA5;NDUFV2;...
|
| Steroid biosynthesis |
-2.17 |
0.00e+0 |
19/20 (95%) |
TM7SF2;DHCR24;HSD17B7;...
|
